Effect of transurethral indwelling catheter on serum prostate-specific antigen level in benign prostatic hyperplasia

被引:23
|
作者
Batislam, E [1 ]
Arik, AI [1 ]
Karakoc, A [1 ]
Uygur, MC [1 ]
Germiyanoglu, RC [1 ]
Erol, D [1 ]
机构
[1] ANKARA HOSP,MINIST HLTH,UROL CLIN,ANKARA,TURKEY
关键词
D O I
10.1016/S0090-4295(96)00386-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The purpose of this prospective study was to determine the influence of indwelling transurethral catheters on the serum prostate-specific antigen (PSA) levels in patients with benign prostatic hyperplasia (BPH). We compared the PSA values of preoperatively catheterized and noncatheterized patients. Methods. Ninety patients undergoing a prostatectomy for benign disease were included. The indwelling catheter (IC) group and noncatheterized (NC) group each consisted of 45 patients. A total of 83 patients who did not have prostate carcinoma were analyzed by means of PSA, PSA density (PSAD), and pathologic presentations. Prostate pathologies that might elevate PSA values were excluded to demonstrate the correlation of PSA levels and standard urethral catheterization. Results. A statistically significant relationship was determined between an indwelling urethral catheter and an elevated serum PSA value. The average PSA level of the IC group was 2.6 times that of the NC group. Conclusions. PSA, PSAD, and age-adjusted PSA levels were elevated above normal ranges in patients with BPH who had an indwelling urethral catheter. Copyright 1997 by Elsevier Science Inc.
引用
收藏
页码:50 / 54
页数:5
相关论文
共 50 条
  • [1] Effect of transurethral resection on serum free/total prostate-specific antigen levels in patients with benign prostatic hyperplasia
    Çetinkaya, M
    Ulusoy, E
    Aki, T
    Kosan, M
    Kundak, C
    Aydos, MM
    Gökkaya, S
    UROLOGY, 1999, 53 (01) : 118 - 120
  • [2] Benign prostatic hyperplasia and prostate-specific antigen
    Pejcic, Tomislav
    Acimovic, Miodrag
    Dzamic, Zoran
    Radovanovic, Milan
    Hadzi-Djokic, Jovan
    VOJNOSANITETSKI PREGLED, 2015, 72 (05) : 447 - 453
  • [3] Seminal plasma prostate-specific antigen level in benign prostatic hyperplasia
    Senkul, T
    Narin, Y
    Iseri, C
    Sen, B
    Karademir, K
    Erden, D
    UROLOGIA INTERNATIONALIS, 2004, 72 (04) : 332 - 334
  • [4] EFFECT OF INFLAMMATION AND BENIGN PROSTATIC HYPERPLASIA ON ELEVATED SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS
    NADLER, RB
    HUMPHREY, PA
    SMITH, DS
    CATALONA, WJ
    RATLIFF, TL
    JOURNAL OF UROLOGY, 1995, 154 (02): : 407 - 413
  • [5] Serum concentrations of prostate-specific antigen after diagnostic procedures and transurethral microwave thermotherapy of benign prostatic hyperplasia
    Daehlin, L
    Frugard, J
    Farstad, M
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (03): : 269 - 273
  • [6] Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia
    Roehrborn, CG
    Boyle, P
    Gould, AL
    Waldstreicher, J
    UROLOGY, 1999, 53 (03) : 581 - 589
  • [7] THE EFFECT OF FINASTERIDE ON PROSTATE-SPECIFIC ANTIGEN IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
    GUESS, HA
    HEYSE, JF
    GORMLEY, GJ
    PROSTATE, 1993, 22 (01): : 31 - 37
  • [8] Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level
    Punglia, RS
    D'Amico, AV
    Catalona, WJ
    Roehl, KA
    Kuntz, KM
    CANCER, 2006, 106 (07) : 1507 - 1513
  • [9] Effect of finasteride on free and total serum prostate-specific antigen in men with benign prostatic hyperplasia
    Matzkin, H
    Barak, M
    Braf, Z
    BRITISH JOURNAL OF UROLOGY, 1996, 78 (03): : 405 - 408
  • [10] Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression
    Levitt J.M.
    Slawin K.M.
    Current Urology Reports, 2007, 8 (4) : 269 - 274